Created in 2013 (Ireland), ADULVANZ own 440 sister brands and 4958 competing brands. ADULVANZ is a brand of Takeda Pharmaceutical, listed on the stock exchange of Francfort. The ISIN, the company's International Securities Identification Number, is JP3463000004. ADULVANZ belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Takeda Pharmaceutical
(ADULVANZ)
over 5 years*
EUR 18.51